99 related articles for article (PubMed ID: 28954807)
41. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.
Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
[TBL] [Abstract][Full Text] [Related]
42. Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG2.
Chen S; Nagel S; Schneider B; Kaufmann M; Meyer C; Zaborski M; Kees UR; Drexler HG; MacLeod RA
Leukemia; 2011 Oct; 25(10):1632-5. PubMed ID: 21647158
[No Abstract] [Full Text] [Related]
43. Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development.
Jurata LW; Kenny DA; Gill GN
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11693-8. PubMed ID: 8876198
[TBL] [Abstract][Full Text] [Related]
44. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
[TBL] [Abstract][Full Text] [Related]
45. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
[TBL] [Abstract][Full Text] [Related]
46. A single ancestral gene of the human LIM domain oncogene family LMO in Drosophila: characterization of the Drosophila Dlmo gene.
Zhu TH; Bodem J; Keppel E; Paro R; Royer-Pokora B
Oncogene; 1995 Oct; 11(7):1283-90. PubMed ID: 7478548
[TBL] [Abstract][Full Text] [Related]
47. The LMO2 oncogene regulates DNA replication in hematopoietic cells.
Sincennes MC; Humbert M; Grondin B; Lisi V; Veiga DF; Haman A; Cazaux C; Mashtalir N; Affar el B; Verreault A; Hoang T
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1393-8. PubMed ID: 26764384
[TBL] [Abstract][Full Text] [Related]
48. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes.
Rabbitts TH
Genes Dev; 1998 Sep; 12(17):2651-7. PubMed ID: 9732263
[No Abstract] [Full Text] [Related]
49. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
Marculescu R; Le T; Simon P; Jaeger U; Nadel B
J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
[TBL] [Abstract][Full Text] [Related]
50. Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors.
Ostendorff HP; Peirano RI; Peters MA; Schlüter A; Bossenz M; Scheffner M; Bach I
Nature; 2002 Mar; 416(6876):99-103. PubMed ID: 11882901
[TBL] [Abstract][Full Text] [Related]
51. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.
Yamada Y; Warren AJ; Dobson C; Forster A; Pannell R; Rabbitts TH
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3890-5. PubMed ID: 9520463
[TBL] [Abstract][Full Text] [Related]
52. Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate.
Sonmez M; Akagun T; Cobanoglu U; Topbas M; Erkut N; Yilmaz M; Ovali E; Omay SB
Hematology; 2009 Aug; 14(4):220-3. PubMed ID: 19635185
[TBL] [Abstract][Full Text] [Related]
53. Does Multicolor Lineage Tracing of Endothelial Cells Provide a Black and White Answer on Clonal Expansion in Post-Natal Angiogenesis?
Yoder MC; Annex BH
Circ Res; 2018 Mar; 122(5):643-645. PubMed ID: 29496791
[No Abstract] [Full Text] [Related]
54. Knockdown of LIMD2 inhibits the progression of ovarian carcinoma through ERK1/2 pathway.
Hu H; Wang Y; Dong Y; Wang L; Chen Y; Zhou Y; Sun L
Mol Biol Rep; 2023 Nov; 50(11):8985-8993. PubMed ID: 37716918
[TBL] [Abstract][Full Text] [Related]
55. Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers.
Rode M; Nenoff K; Wirkner K; Horn K; Teren A; Regenthal R; Loeffler M; Thiery J; Aigner A; Pott J; Kirsten H; Scholz M
PLoS One; 2022; 17(4):e0266897. PubMed ID: 35446883
[TBL] [Abstract][Full Text] [Related]
56. LMO2 (LIM Domain Only 2) and Endothelial Cell Migration in Developmental and Postnatal Angiogenesis.
Ganta VC; Annex BH
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1806-1808. PubMed ID: 28954807
[No Abstract] [Full Text] [Related]
57. Lmo2 (LIM-Domain-Only 2) Modulates Sphk1 (Sphingosine Kinase) and Promotes Endothelial Cell Migration.
Matrone G; Meng S; Gu Q; Lv J; Fang L; Chen K; Cooke JP
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1860-1868. PubMed ID: 28775072
[TBL] [Abstract][Full Text] [Related]
58. LIM Domain Only 2 Regulates Endothelial Proliferation, Angiogenesis, and Tissue Regeneration.
Meng S; Matrone G; Lv J; Chen K; Wong WT; Cooke JP
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792641
[TBL] [Abstract][Full Text] [Related]
59. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
60. LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).
Park CG; Sohn YW; Kim EJ; Kim SH; Kim SC; Kim H
Tumour Biol; 2016 Feb; 37(2):2473-80. PubMed ID: 26383528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
